Hi Long_hual,
You mentioned,
"My understanding is that generics have a relatively short life span, measured in years rather than decades."
Where did you get this info from? I would presume the only thing that would affect a generic product once approved would be competition and whether a better/ or more effective product replaces it?
Cheers
News: ACR Acrux Posts FY Net Loss After Tax A$14.2 Mln, page-7
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.3¢ |
Change
-0.003(4.55%) |
Mkt cap ! $18.31M | |||
| Open | High | Low | Value | Volume |
| 6.7¢ | 6.7¢ | 6.3¢ | $34.65K | 539.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 123229 | 6.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 235749 | 3 |
View Market Depth
| Last trade - 14.04pm 18/07/2024 (20 minute delay) ? |
| ACR (ASX) Chart |